| Dec, 15 | Tarceva receives positive EU opinion for the treatment of metastatic pancreatic cancer more.. |
| Dec, 15 | Roche offers the FDA additional Mircera data more.. |
| Dec, 13 | Changes to the Roche Board of Directors and executive management more.. |
| Dec, 12 | Avastin shows positive outcomes in patients with advanced kidney cancer more.. |
| Dec, 11 | Xeloda meets primary endpoint in multinational Phase III advanced colorectal cancer study more.. |
| Dec, 6 | NT-proBNP Test could save the North American healthcare system nearly 600 million US dollars more.. |
| Dec, 5 | New nanomechanical method for detecting disease- and treatment-relevant genes more.. |
| Dec, 4 | Employees support children affected by HIV/AIDS at the Annual Roche AIDS Walk more.. |
| Nov, 28 | Update on Tamiflu: no increase in drug resistance observed more.. |
| Nov, 20 | Mircera - first drug to correct anaemia in all chronic kidney disease patients with a simple twice-monthly dosing schedule more.. |
| Nov, 16 | The Salzburg Festival and Roche launch the "Continents..." cultural project more.. |
| Nov, 16 | Statement - Label changes for Tamiflu more.. |
| Oct, 20 | Science Magazine ranks Roche No. 3 among Top Employers in the Biotech and Pharmaceutical Industries more.. |
| Oct, 17 | Roche´s nine-month sales hit record high more.. |
| Oct, 17 | Roche and InterMune sign agreement to collaborate on the research, development and commercialization of Hepatitis C Protease Inhibitors more.. |
| Oct, 13 | Roche files Herceptin plus hormonal therapy for advanced HER2-positive breast cancer with European Authorities more.. |
| Oct, 12 | UNICEF and Roche announce partnership to improve the lives of children orphaned by AIDS in Africa more.. |
| Oct, 12 | Avastin approved in US for first-line treatment of most common form of lung cancer more.. |
| Oct, 9 | U.S. regulatory authority lifts import alert for Accu-Chek Spirit insulin pump system more.. |
| Oct, 2 | Additional benefit for patients resulting from combination therapies with Roche cancer medicines more.. |
| Oct, 2 | Tamiflu readily available for 2006/2007 influenza season more.. |
| Sep, 22 | First Technology Transfers from Roche to enable local production of HIV medicine for Africa more.. |
| Sep, 14 | Roche development plans: a clear commitment to the Basel site more.. |
| Sep, 1 | George Benjamin is fourth Roche Commissions composer more.. |
| Sep, 1 | International Trade Commission rules in Roche´s favour - Mircera case terminated more.. |
| Aug, 8 | Avastin filed in Europe for treatment of most common form of lung cancer more.. |
| Jul, 31 | Avastin and Xeloda meet primary endpoints in large Phase III first line metastatic colorectal cancer study more.. |
| Jul, 28 | In the interests of patients, Roche will consider all options following CHMP opinion on Tarceva in pancreatic cancer more.. |
| Jul, 21 | Xeloda filed in Europe for treatment of advanced stomach cancer more.. |
| Jul, 20 | Roche in the first half of 2006: Outstanding growth more.. |
| Jul, 19 | Roche exercises its option to license Ipsen´s anti-diabetic medicine for type 2 diabetes more.. |
| Jul, 17 | Actelion and Roche enter into autoimmune disorder collaboration more.. |
| Jul, 17 | Mircera (C.E.R.A.) first drug to directly convert dialysis patients to once-monthly dosing schedule more.. |
| Jul, 11 | MabThera approved in Europe for maintenance therapy in patients with common form of lymphoma more.. |
| Jul, 11 | MabThera approved for use in rheumatoid arthritis in Europe more.. |
| Jul, 10 | Avastin filed in Europe for first-line treatment of women with advanced breast cancer more.. |
| Jun, 27 | US Phase III study of Avastin in advanced pancreatic cancer does not meet primary endpoint more.. |
| Jun, 22 | New evidence shows MabThera inhibits joint damage in patients with rheumatoid arthritis more.. |
| Jun, 3 | New data show impressive survival benefit for Herceptin in early-stage HER2-positive breast cancer more.. |
| Jun, 2 | MabThera recommended for approval in rheumatoid arthritis in Europe more.. |
| May, 29 | Herceptin added to hormonal therapy prolongs progression-free survival for patients with advanced HER2-positive breast cancer more.. |
| May, 26 | Avastin filed with FDA in US for treatment of women with advanced breast cancer more.. |
| May, 24 | Herceptin approved in Europe for early use in HER2-positive breast cancer more.. |
| May, 23 | Recruitment to resume in AVANT international phase III trial in post-surgical adjuvant colon cancer more.. |
| May, 19 | Transparency in clinical trials: more than 300 protocol and study results published on www.roche-trials.com since April 2005 more.. |
| May, 16 | Roche reaches agreement with Aspen to provide influenza medicine for Africa more.. |
| May, 8 | New Genetic Research Method Sheds Light on Drug Metabolism more.. |
| May, 3 | Cambodia Treatment Programme enrols over 1000 HIV/AIDS patients more.. |
| Apr, 28 | Chugai submitted Actemra in rheumatoid arthritis and a severe form of juvenile arthritis for approval in Japan more.. |
| Apr, 28 | Herceptin receives positive opinion in Europe for early use in HER2-positive breast cancer more.. |
| Apr, 27 | Roche submits European marketing application for novel anaemia drug CERA more.. |
| Apr, 26 | Roche showed continued strong sales growth in the first quarter 2006 - sales up by 15% more.. |
| Apr, 21 | Chugai files innovative cancer medicine Avastin for fast approval in Japan more.. |
| Apr, 20 | Roche submits application to FDA to market CERA for the treatment of renal anaemia more.. |
| Apr, 19 | Rapid response stockpile of Tamiflu now ready and available to the World Health Organisation (WHO) more.. |
| Apr, 12 | Avastin filed in US for treatment of most common form of lung cancer more.. |
| Apr, 6 | Oral chemotherapy Xeloda shown to be effective in stomach cancer more.. |
| Mar, 31 | New Bonviva Quarterly Injection Approved in Europe for Postmenopausal Osteoporosis more.. |
| Mar, 16 | Roche update on Tamiflu for pandemic influenza preparedness more.. |
| Mar, 1 | FDA Approves First Rheumatoid Arthritis Indication for Rituxan (MabThera) more.. |
| Feb, 27 | Roche raises dividend by 25 percent more.. |
| Feb, 17 | Roche files Herceptin for early-stage HER2-positive breast cancer with European Authorities more.. |
| Feb, 13 | Recruitment temporarily suspended in an international phase III trial (AVANT) in post-surgical adjuvant colon cancer more.. |
| Feb, 1 | Annual Media Conference more.. |
| Feb, 1 | Roche 2005: Record sales and operating profit more.. |
| Jan, 31 | Tamiflu gains approval in Europe for prevention of influenza in children aged 1 to 12 years more.. |
| Jan, 27 | European positive opinion for first quarterly I.V. injection for postmenopausal osteoporosis more.. |
| Jan, 24 | US FDA joint advisory committee recommends approval of weight loss drug Orlistat 60mg capsules for over the counter use more.. |
| Jan, 19 | Statement - In response to paper by Jefferson et al., published in the Lancet, 19 January 2006, "Antivirals for influenza in healthy adults: systematic review" more.. |
| Jan, 17 | Roche donates a further 2 million treatment courses of antiviral Tamiflu to the WHO for regional stockpiling more.. |
| Jan, 12 | Roche offers help to local manufacturers to produce HIV medicine for sub-Saharan Africa and Least Developed Countries more.. |
| Jan, 12 | Roche´s rapid sepsis test now available in the European Union more.. |
| Jan, 9 | FDA approves first quarterly I.V. injection for postmenopausal osteoporosis in US more.. |
| Jan, 9 | Roche and Amira Pharmaceuticals announce innovative alliance model more.. |
print this page